Center Highlights
Receiving recognition from news outlets and outside organizations and providing updates about the center, highlighting the work of the CTBH team.
CTBH activities are recognized locally and nationally by news outlets and outside organizations. Notable activities of CTBH affiliates include the development of state of the art technologies, publication of a book, and presenting at the White House.
Dartmouth Innovation Accelerator for Digital Health kicks off with two-day workshop
The Accelerator, a partnership between the Center for Technology and Behavioral Health and The Magnuson Center for Entrepreneurship, will help researchers bring their technology to market.
Read MoreCentre for Digital Health Interventions prepares chapter summaries of recently released book: Digital Therapeutics for Mental Health and Addiction
The Centre for Digital Interventions is preparing brief chapter summaries of the recently published textbook “Digital Therapeutics for Mental Health and Addiction: The State of the Science and Vision for the Future” to introduce readers to the content.
The book (edited by Nicholas Jacobson, Tobias Kowatsch, and Lisa Marsch) explores the field of digital therapeutics and presents content for an extensive audience.
Read MoreCTBH in the News! New Dartmouth Innovation Accelerator for Digital Health announced during digital health summit
CTBH is pleased to share the article below on our recent Digital Health Summit and the launch of the Dartmouth Innovation Accelerator for Digital Health.
‘Digital Therapeutics Summit Held at Dartmouth’ (Geisel News – November 10, 2022 – Full Article)
Read MoreCTBH’s Andrew Campbell wins the 2022 ACM UbiComp 10-year Impact Award!
Congratulations to Andrew Campbell, Director of CTBH’s Emerging Technologies and Data Analytics Core, on winning the prestigious 2022 ACM UbiComp 10-year Impact Award for StressSense, a mobile app developed in 2012 by Professor Campbell’s advisee, Hong Lu. The winning paper “StressSense: Detecting stress in unconstrained acoustic environments using smartphones” describes the first noninvasive system that can detect stress based on changes in human speech production in diverse real-life acoustic scenarios.
Read MoreDigital health summit brings together leaders in digital therapeutics
The event, hosted by the Center for Technology and Behavioral Health (CTBH) and The Magnuson Center for Entrepreneurship at Dartmouth College, will cover the current state of digital therapeutics, and explore the paths to global deployment of this innovative type of healthcare.
Read MoreCTBH announces publication of Elsevier book led by Center leadership and colleagues!
CTBH is pleased to announce the publication of Digital Therapeutics for Mental Health and Addiction: The State of the Science and Vision for the Future (edited by Nicholas Jacobson, Tobias Kowatsch, and Lisa Marsch).
Read MoreCTBH’s Nicholas Jacobson is awarded funding to study personalized digital intervention targeting anxiety and depressive symptoms in reducing cancer risk
Congratulations to Nicholas Jacobson, CTBH Deputy Director of the Treatment Development & Evaluation Core, on his recent award from the Dartmouth Cancer Center! The project, Precision Prevention of Cancer at Scale: Using Digital Phenotyping to Monitor and Target Modifiable Mental Health Risk Factors via a Smartphone App is part of the Dartmouth Cancer Center’s new Precision Prevention initiative and will evaluate the efficacy of a personalized digital intervention targeting anxiety and depression in reducing cancer risk.
Read MoreCTBH Faculty Affiliate Paul Barr is awarded NIA funding to study the effect of audio recordings of clinic visits in older adults with multimorbidity
Congratulations to CTBH Faculty Affiliate, Paul Barr and colleagues from Vanderbilt University Medical Center and the University of Texas Medical Branch on their recent R01 grant from the National Institute on Aging (NIA)! The five-year study, REPLAY Trial. The Effect of Clinic Visit Audio Recordings for Self-Management in Older Adults, will involve multisite trials to determine the impact of implementing audio recordings of clinic visits in older adults with multimorbidity, including diabetes, on their selfmanagement ability, health outcomes or healthcare utilization.
Read MoreCTBH’s Varun Mishra receives an IMWUT Distinguished Paper Award!
Varun Mishra, Deputy Director of CTBH’s Emerging Technologies and Data Analytics Core received an IMWUT Distinguished Paper Award, in recognition for his outstanding and exemplary contributions to the research community. His winning paper “Detecting Receptivity for mHealth Interventions in the Natural Environment” was published in the Proceedings of the ACM on Interactive, Mobile, Wearable and Ubiquitous Technologies ( PACM IMWUT), Volume 5, June 2021, and his award was announced during the UbiComp/ISWC 2022 Awards Ceremony on September 14, 2022.
Read MoreCTBH’s Jacob Borodovsky receives NIDA funding to produce a model of adolescent digital technology use, substance use, and mental health
Congratulation to CTBH Research Team member Dr. Jacob Borodovsky on receiving an R21 award from the National Institute on Drug Abuse (NIDA)! In this project, Clarifying the Relations Among Youth Technology Use, Substance Use and Mental Health, Jake and colleagues plan to develop a new, empirically derived model of adolescent digital technology use, substance use, and mental health.
Read MoreCTBH presents digital mental health implementation research in Latin America at World Bank webinar
Members of the Project DIADA (Detection and Integrated Care for Depression and Alcohol Use in Primary Care) team, from the NIMH funded implementation research project entitled “Scaling Up Science-based Mental Health Interventions in Latin America” recently participated in a webinar series sponsored by World Bank Group, PHCPI, and SaludDerecho.
Read MoreCTBH Faculty Affiliate Saeed Hassanpour receives NIH funding to apply innovative approaches to improve histopathological analysis
Congratulations to Dr. Saeed Hassanpour and his team on receiving a multi-year award from the National Library of Medicine! The project, Advancing Digital Pathology through Novel Machine Learning Methodologies aims to improve the performance and accuracy of existing deep learning models for histopathological analysis, using innovative approaches that will address current challenges in digital pathology while saving time and resources in digitization efforts.
Read MoreCTBH welcomes Drs. Andrew Campbell and Varun Mishra in Core leadership roles!
CTBH is delighted to announce Dr. Andrew Campbell as the Director, and Dr. Varun Mishra as the Deputy Director, of the Emerging Technologies and Data Analytics (ETDA) Core of the Center for Technology and Behavioral Health’s (CTBH) NIH P30 “Center of Excellence”. We greatly thank Dr. David Kotz for his excellent prior leadership of CTBH’s ETDA Core since the inception of the Core.
Read MoreCTBH Faculty Affiliate Paul Barr receives PCORI funding to study effectiveness of sharing audio recordings of clinic visits
Congratulations to Dr. Paul Barr and his team on receiving receiving a five-year, $7 million award from the Patient-Centered Outcomes Research Institute (PCORI)!
This project, entitled CHRONICLE (Comparing Healthcare Visit Recording and Open Notes to Improve the Chronic Illness Care Experience for Older Adults) will evaluate various approaches to communicating healthcare visit information to facilitate the day to day self-care of older adults with multimorbidity.
Read MoreCTBH Faculty Affiliate Paul Barr receives NIA funding to study audio recordings in dementia care
Congratulations to Dr. Paul Barr and his team on receiving an R01 award from the National Institute on Aging (NIA) to design an intervention that enhances interpersonal communication in triadic (persons living with dementia, their caregivers, and their clinicians) visits using audio recordings.
Read MoreCTBH Faculty Affiliates Temiloluwa Prioleau and Varun Mishra selected as mHealth scholars
Congratulations to CTBH Faculty Affiliates Temiloluwa Prioleau, PhD and Varun Mishra, PhD on being selected as scholars for the 2022 NIH mHealth Training Institute (mHTI)!
Read MoreCTBH in the News! Publication from CTBH team finds association between antidepressant use and measured movement
‘Detecting Potential Medication Side Effects in Treating Depression and Anxiety’ (Geisel News – April 19, 2022 – Full Article)
Article Excerpt: New findings in a cross-sectional study by Michael V. Heinz, MD, a postdoctoral research fellow affiliated with the AI and Mental Health: Innovation in Technology Guided Healthcare Lab at Geisel School of Medicine’s Center for Technology and Behavioral Health, published in JAMA Network Open, suggest a significant association between antidepressant use and measured movement, even when accounting for depression. Individuals treated with antidepressants had an overall lower level of physical activity.
CTBH Faculty Affiliate Jesse Dallery receives PCORI funding to compare the effectiveness of digital therapeutics for smoking cessation
Congratulations to CTBH Faculty Affiliate Jesse Dallery, Professor in the Department of Psychology at the University of Florida, and team on their recently awarded PCORI project, Comparative Effectiveness of Mobile Health Smoking Cessation Approaches Among Underserved Patients in Primary Care.
Read MoreCTBH Faculty Affiliate Paul Barr receives NCI funding to develop an online platform for patients with depression in cancer settings
Congratulations to CTBH Faculty Affiliate Paul Barr, Associate Professor, The Dartmouth Institute for Health Policy & Clinical Practice, and colleagues on their R21 award from the National Cancer Institute (NCI) to develop an online platform for patients with depression in cancer settings.
Read MoreCTBH in the News! Team receives distinguished recognition for work on a new model for access to evidence-based mental health care
‘Geisel School of Medicine and Dartmouth-Hitchcock Researchers Receive Prestigious Colombian National Academy of Medicine Award’ (Geisel News– October 28, 2021 – Full Article)
Article Excerpt: Today, researchers from the Center for Technology and Behavioral Health (CTBH) at Dartmouth’s Geisel School of Medicine, Dartmouth-Hitchcock (D-H), and Pontificia Universidad Javeriana in Bogotá, Colombia, received an award—one of that country’s most prestigious in medicine—from Colombia’s National Academy of Medicine for their work implementing a new primary care model for widespread access to diagnosis and treatment of depression and unhealthy alcohol use. This care model harnesses mobile health technology to increase the reach of science-based mental health care.
CTBH Faculty Affiliate Elizabeth Murnane receives funding from the US National Academy of Medicine to study music-based interventions in healthy aging
Congratulations to CTBH Affiliate Elizabeth Murnane, the Charles H. Gaut and Charles A. Norberg Assistant Professor in the Thayer School of Engineering at Dartmouth College, on her new funding from the US National Academy of Medicine as part of their Healthy Longevity Global Competition.
Read MoreCTBH’s NIH P30 Center grant renewed for another 5 years!
We are pleased to share the news that CTBH has been awarded a 5-year renewal of its P30 “Center of Excellence” grant from the U.S. National Institute on Drug Abuse (NIDA). CTBH is designed to use science to inform the development, evaluation and sustainable implementation of a wide array of technology-based tools for behavioral health, and we look forward to the opportunity to continue to grow and expand our work.
Read MoreCTBH in the News! Profs. Lorie Loeb and Jeremy Manning discuss FitWit project, funded through CTBH Pilot Core
‘Into the Wild’ (Dartmouth Medicine – August 6, 2021 – Full Article)
Article Excerpt: Neuroscientist Jeremy Manning, PhD, wants to understand the causal link between exercise, mental health, and cognitive performance—his Contextual Dynamics Lab researches human memory and he has a few ideas about how the three may be connected… With funding from CTBH (Center for Technology and Behavioral Health)’s Pilot Core, Manning and (Lorie) Loeb pulled together Dartmouth-wide experts in human memory, physiological changes associated with exercise and cognition, remote sensing technologies and software development, and data analysis/app design—a collaboration that included undergraduate and graduate students as well as faculty—to launch the pilot study.
CTBH in the News! CTBH Director Lisa Marsch talks about digital therapeutics as keynote speaker at the OPEN MINDS Technology & Analytics Institute
Are You Ready For A Prescription For Treatment Tech? (OPEN MINDS– April 22, 2021 – Full Article)
By Monica E. Oss
The global digital therapeutics market size was estimated at $3.5 billion in 2020 and is expected to reach $4.4 billion in 2021. Analysts estimate a compound annual growth rate of 23.1% and predict that the market will reach $19.1 billion by 2028 (see Digital Therapeutics Market Size & Trends Report, 2021 – 2028). Investments by venture capital as well as pharmaceutical companies in this space are growing.
Why does this matter to specialty provider organizations caring for consumers with chronic and complex conditions? And why now? We got some great perspectives on the current possibilities with digital therapeutics from Lisa Marsch, Ph.D., Director of the Center for Technology and Behavioral Health at Dartmouth College, our keynote speaker at the OPEN MINDS Technology & Analytics Institute during the session, Digital Therapeutics For Behavioral Health: Anytime/Anywhere Health Care and the ensuing thought leader discussion. We talked with her about how digital therapeutics can improve treatment outcomes for consumers with mental illness and substance use disorders when used in conjunction with traditional service delivery and medications.
How is a digital therapeutic different from a wellness app? Dr. Marsch defined digital therapeutics as clinical grade software to prevent, treat, or manage a disease or disorder. She said, “It’s taking clinically validated medical treatments for various health conditions and delivering those treatments entirely through software. So it’s packaging an entire model of care into a seamless digital delivery platform.” Digital therapeutics could include cognitive behavioral therapy, problem solving therapy, techniques to promote medication adherence, and more. However, there is no synchronous communication with clinical professionals—all content and functionality is embedded in the interactive software platform that delivers the therapeutic tools.
Dr. Marsch said, “It’s kind of like a clinician in your pocket. Digital therapeutics tools can extend the reach and the impact of clinicians, be available to patients 24/7, and really reinforce what’s being offered to them in a clinical setting.” Prescription digital therapeutics require authorization by the Food and Drug Administration (FDA), and can only be prescribed by a clinical professional after clinical trials. And, the FDA recently sped approval of digital therapeutics—particularly in psychiatry (see Enforcement Policy For Digital Health Devices For Treating Psychiatric Disorders During the Coronavirus Disease 2019).
What’s out there? Digital therapeutics fall into four categories—those that address a medical condition, manage or prevent a medical disorder or disease, support medication, or treat a medical disease or disorder.
Digital therapeutics that address a medical condition include The Dexcom G6 system for glucose monitoring combined with BlueStar, which is FDA cleared for Type 2 diabetes self management (see Welldoc & Dexcom Expand Strategic Partnership To Integrate Platforms & Offer An Integrated Type 2 Diabetes Management Solution).
Among digital therapeutics that help manage disorders is the game-based prescription digital therapeutic, EndeavorRx, to improve attention function in children with attention deficit/hyperactivity disorder (see FDA Approves First Game-Based Prescription Digital Therapeutic For Children With ADHD).
Digital therapeutics that optimize medication include smart pills equipped with embedded sensors or cameras, such as Abilify MyCite, that track ingestion and alert care coordinators about missed dosages (see OIG Approves Otsuka Plan To Loan Smartphones To People Taking Its Digital Medicine Antipsychotic, Abilify MyCite).
A digital therapeutic that treats a medical disease or disorder is the FDA-cleared Freespira to reduce or eliminate symptoms of panic attacks, panic disorder, and post-traumatic stress disorder (PTSD) in 28 days (see Highmark Health Expands Access to Freespira’s Digital Therapeutic Treatment for Panic Attacks, Panic Disorder & PTSD). Germany recently approved Deprexis, a depression treatment therapeutic, for medical prescription and reimbursement (see Germany Approves Digital Mental Health Apps For Prescription). Otsuka Pharmaceutical and Click Therapeutics have launched a fully remote clinical trial to measure the effectiveness of a digital therapeutic intervention for major depressive disorder (see Otsuka & Click Therapeutics To Develop Digital Therapeutics For Major Depressive Disorder). CenteredVR, a virtual reality-enabled mindfulness and stress management program for clinical professionals has been shown to decrease stress levels by 34% on average, reduce anxiety, and enhance the overall mental health and well-being (see BehaVR’s CenteredVR Eases Emotional Toll Of COVID-19 On Health Care Workers).
Are digital therapeutics effective? Over many years of research, digital therapeutics used in behavioral health treatment have yielded outcomes that are comparable to or better than care delivered by clinical professionals. For example, an intensive behavior change digital tool for substance use disorders (based on the community reinforcement model used by clinical professionals) tested by Dr. Marsch and her team has been shown to roughly double drug abstinence rates when used as part of the therapeutic model, compared to standard addiction treatment. A study found that 86% of consumers treated with Freespira’s digital therapeutic for panic attacks were symptom-free immediately after treatment and 73% were still symptomfree 12 months post treatment. The majority of patients were free of panic attacks and/or reduced their symptoms and avoidance behaviors one year after Freespira treatment. Mean overall medical costs were reduced by 35% from $548 to $358 per member per month (PMPM). There was a 65% reduction in emergency department costs from $87 to $30 PMPM. Median pharmacy costs were reduced by 68% from $73 to $23 per member per month. (see Evaluating The Impact Of Freespira On Panic Disorder Patients’ Health Outcomes & Healthcare Costs Within The Allegheny Health Network).
Digital therapeutic tools allow personalization of care. Dr. Marsch explained, “They don’t always have to work the same way. We don’t have to have 12 sessions or eight sessions of treatment every time. Digital therapeutics can be responsive to the needs and preferences of the individual and the changing clinical trajectories of individuals over time.” These tools also expand access to care, helping to reach the majority of people who have a substance use disorder or mental health problem but don’t seek care in traditional models. “If a digital therapeutic is the only thing that someone would try in the privacy of their own home, it can be a stepping stone to seeking care with a clinician in a health care system,” Dr. Marsch said. However, it’s important to be mindful of the digital divide and look for workarounds when lack of bandwidth impedes access for consumers.
So how do clinical professionals prescribe from the plethora of digital therapeutics starting to enter the market? The key is what consumers will get coverage for. A digital therapeutic currently costs $900 to $1,200 out of pocket but the big challenge is that the Centers for Medicare and Medicaid is not yet reimbursing for digital therapeutics. However, more employers and health plans are starting to cover the cost—and CVS and ExpressScipts are developing digital therapeutic formularies. Children’s Community Health Plan in Wisconsin has made Freespira’s digital therapeutic for panic attacks and PTSD available to all consumers, including those covered by Medicaid (see Children’s Community Health Plan Is First In Wisconsin To Offer New Digital Therapeutic Treatment For Panic Attacks, Panic Disorder, & PTSD). Freespira is also covered by Highmark, the fourth-largest Blue Cross Blue Shield-affiliated health plan serving 5.6 million health plan members in Pennsylvania, Delaware, and West Virginia (see Highmark Health Expands Access To Freespira’s Digital Therapeutic Treatment For Panic Attacks, Panic Disorder & PTSD). And, in Indiana, the state is providing access to Pear Therapeutics’ FDA-authorized prescription digital therapeutics for the treatment of substance use and opioid use disorder to participating provider organizations in a variety of outpatient treatment settings and opioid treatment programs (see Pear Announces Indiana Family & Social Services Administration Division Of Mental Health & Addiction Will Provide Access To Prescription Digital Therapeutics For Substance Use & Opioid Medication Addiction).
And for provider organizations that are in (or are considering) value-based payment arrangements, tools that can improve outcomes for consumers and save costs system-wide can increase “preferred provider” status with payers. And for provider organizations in fee-for-service arrangements, prescribing digital therapeutics for consumers could free up the time of clinical professionals (with fewer face-to-face sessions) and help them see more consumers.
For more on enhancing your digital toolbox and improving treatment efficacy, check out these resources in The OPEN MINDS Circle Library:
- Strategy & Sustainability For The Next Normal: It’s the Technology, @)(*@#&$!
- Specialty Care Strategy For A Tech-Enabled Future
- Digital Transformation – The OPEN MINDS Guide To Getting The Most Value From Your Technology Investments
- The Specialty Provider Organization Technology Checklist
- Adding AI To Your Digital Toolbox Can Add Value
- “Plussing Up” For The Digital Era: Robots Become Reality
- Are We Ready For AI-Driven Care? It Depends…
- Expanding Your Digital Toolbox With Chatbots
- When The Answer Is “I’m Sorry, I Can’t Help You With That”
- The Technology Triple Whammy
And for even more, join us on May 13 for the Executive Web Forum, Making Value-Based Reimbursement Work – Best Practices In Program Design & Management. Ashley Gibson, Director Of Payer Relations, Contracts & Utilization, Hazelden Betty Ford Foundation and Donna Esposito, Director of Payer Relations, THRIVE DETECT, will share case studies on the development, design, and management of value-based reimbursement programs.
This reprint appears with the permission of OPEN MINDS. For more information, visit their website at www.openminds.com. To contact the author, email openminds@openminds.com.
CTBH in the News! CTBH’s Ryan Halter and John Batsis receive NIH funding for their remote physical therapy monitoring system
‘Dartmouth Startup Wins Funding for Remote Physical Therapy Monitoring System’ (Dartmouth Engineering – April 20, 2021 – Full Article)
Article Excerpt: A team of researchers from Dartmouth has been awarded nearly $225,000 from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to develop and test “BandPass,” a remote-sensing resistance band exercise system that would allow health care providers to monitor, evaluate, and guide patients as they use the device in their homes.
CTBH in the News! CTBH Faculty Affiliate Paul Barr interviewed for his work in Open Recordings in Psychology Today
‘Capturing Recordings of Your Medical Encounters. Are some discussions too important not to record?’ (Psychology Today – April 22, 2021 – Full Article)
Article Excerpt: … with colleagues at the Preference Laboratory in Dartmouth, (Dr. Paul Barr) began exploring the nascent phenomenon of patients secretly recording their physician visits. Then, after attending a 2014 lecture given by Sigel Bell of the Open Notes research group (more here), Barr started to see huge potential benefits in openly recorded clinic visits and started to learn more about the idea. A theme that kept popping up was that while many patients felt uncomfortable about making secret recordings, they did so anyway because “some discussions were too important not to record.”
CTBH Core Director David Kotz to lead Dartmouth’s partnership with Vibrent Health under NIH’s All of Us Research Program
David Kotz, PhD, Director of CTBH’s Emerging Technologies & Data Analytics Core, will collaborate with Vibrent Health, the Participant Technology Systems Center of NIH’s All of Us Research Program, to develop innovative approaches for upholding privacy and security for program participants during the collection of health-related data.
Read MoreCTBH Director Dr. Lisa A. Marsch to deliver a keynote address at 2020 OPEN MINDS Technology & Analytics Institute
Dr. Marsch will deliver the address, Digital Therapeutics For Behavioral Health: Anytime/Anywhere HealthCare, virtually on March 11, 2021. A forum will follow to further the discussion and allow for questions. In anticipation of the presentation, and to offer additional insight into the field of digital therapeutics, OPEN MINDS interviewed Dr. Marsch and released an Executive Briefing entitled “Supercharging The Workforce With Digital Therapeutics”.
Link to the full article here (subscription required to view, no fee).
The Northeast Node of the National Drug Abuse Treatment Clinical Trials Network receives NIDA funding to study a pharmacist-integrated model of medication treatment for opioid use disorder
NIDA recently awarded a grant to the Northeast Node of the National Drug Abuse Treatment Clinical Trials Network to investigate how to optimally engage pharmacies, currently an underutilized resource in OUD treatment, as key partners in collaborative, integrated care models designed to expand access to evidence-based MOUD treatment.
Read MoreCTBH’s Sarah Lord and Daisy Goodman receive supplemental award from PCORI to address how the pandemic has changed the care of pregnant women with opioid use disorder and their infants
Sarah Lord, PhD, Director of the Dissemination & Implementation Core of CTBH, and Daisy Goodman, CNM, DNP, MPH, CTBH Center Partner, were awarded a supplemental grant from the Patient-Centered Outcomes Research Institute (PCORI) to enhance their existing study examining optimal care for pregnant women with opioid use disorder and their infants.
Read MoreCTBH Core Director Alan Budney is awarded a grant from NIDA for developing a standardized measure of cannabis use
Alan Budney, PhD, Director of the Treatment Development and Evaluation Core of CTBH, and Multiple Principal Investigator, Deborah Hasin, PhD were recently awarded a 5-year grant from the National Institute on Drug Abuse (NIDA) for the development and validation of a rigorous standardized measure of cannabis consumption.
Read MoreCTBH Faculty Affiliate Paul J. Barr receives funding from the Diamond Endowment Program to continue research on video/audio recordings of ALS patients and their caregivers
CTBH Faculty Affiliate, Paul J. Barr, PhD and Multiple Principal Investigator, Jeffrey A. Cohen, MD have been granted an award from the Diamond Endowment Program at Geisel School of Medicine at Dartmouth and Dartmouth-Hitchcock Medical Center. This funding will extend Dr. Barr’s current research on video/audio recordings to patients with Amyotrophic Lateral Sclerosis (ALS) who receive care at Multidisciplinary ALS Clinics and their caregivers.
Read MoreCTBH Investigator Nicholas Jacobson receives NIH funding for major depressive disorder research
CTBH faculty affiliate Nick Jacobson, PhD has been awarded a 5 year grant from the National Institute of Mental Health (NIMH) to conduct research that aims to test the accuracy of personalized, subtyped, and cohort-based modeling techniques and uncover personalized digital biomarkers of moment-to-moment changes in major depressive disorder (MDD) symptoms.
Read MoreCTBH Faculty Affiliate Temiloluwa Prioleau receives NSF award for COVID-19 research
Dr. Temi Prioleau, computer science professor and CTBH affiliate, has received a new grant from the National Science Foundation to address knowledge gaps about the COVID-19 pandemic, including a focus on better understanding health disparities among Black Americans.
Read MoreCTBH Deputy Director Catherine Stanger awarded $3 million from NIH for diabetes research
Catherine Stanger, PhD, has been awarded a 5 year grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to test the effectiveness of innovative behavioral intervention tools in helping to improve the health of high-risk patients who suffer from Type 1 diabetes. The project, Thinking Outside the Clinic: A Digital Health Approach for Young Adults with Type 1 Diabetes, addresses a key public health issue with broad applicability to many diseases and health behaviors: how to help people follow a complicated medical regimen and achieve better health outcomes.
See here for a press release from Dartmouth’s Geisel School of Medicine.
CTBH Investigator Nicholas Jacobson named the Frank and Myra Weiser Scholar in the Neurosciences at the Geisel School of Medicine at Dartmouth College
CTBH Investigator, Nicholas Jacobson has been named the Frank and Myra Weiser Scholar in the Neurosciences at the Geisel School of Medicine at Dartmouth College. This funding will be used to support Dr. Jacobson’s work in advancing digital health for anxiety and depression.
Read MoreCTBH hosts Dr. Elad Yom-Tov from Microsoft Research for the first CTBH Seminar of 2020
CTBH had the pleasure of hosting Dr. Elad Yom-Tov, Principal Researcher at Microsoft Research, for the first CTBH Seminar of 2020 entitled “Novel collection of internet data to study issues of mental health”.
Read MoreCTBH Research Spotlight! CTBH was recently awarded over $4M in funding from the NIH as part of the HEAL Initiative to improve treatment of opioid addiction
CTBH has just received over $4M in grants from the National Institutes of Health (NIH) to improve the treatment of opioid addiction through its Helping to End Addition Long-term (HEAL) Initiative. This funding to CTBH will support “the translation of medical research on opioid addiction treatment to real-world practice,” according to the offices of Senator Shaheen and Senator Hassan who recently announced awarding of this federal funding to New Hampshire.
Read MoreCTBH welcomes new faculty member, Paul J. Barr
Paul J. Barr, MSc, PhD joins as CTBH faculty member, with an appointment of Assistant Professor at the Dartmouth Institute for Health Policy and Clinical Practice, with advanced training in quantitative and qualitative methods. Paul received a BSc in Psychology, an MSc in Public Health (Health Services Research stream) at the London School of Hygiene and Tropical Medicine, England, and a PhD in Health Services Research from Queen’s University Belfast, Ireland.
Read MoreCTBH and Dartmouth Data Analytics Association (DDAA) host Dr. Susan Murphy
CTBH and DDAA had the pleasure of hosting Dr. Susan Murphy (Professor of Statistics, Radcliffe Alumnae Professor at the Radcliffe Institute and Professor of Computer Science at the Harvard John A. Paulson School of Engineering and Applied Sciences Harvard University) for a presentation on “Using Data to Inform Just-in-Time Adaptive Intervention Development for Digital Health”.
Read MoreCTBH welcomes new faculty member, Nicholas Jacobson
Nicholas (Nick) Jacobson, PhD joins as CTBH faculty member, with an appointment of Assistant Professor in the Department of Biomedical Data Science and a secondary appointment in the Department of Psychiatry at Dartmouth. Nick received his PhD in Clinical Psychology from Penn State University and completed a clinical fellowship at Massachusetts General Hospital/Harvard Medical School.
Read MoreCTBH in the News! CTBH leading Latin American Mental Health Project
‘Building Mental Health Care into Latin American Primary Care’ (Dartmouth Medicine Magazine – Spring 2017 – Full Article)
Article Excerpt: A five-year initiative, the Latin American Mental Health Project is funded by a grant from the National Institute of Mental Heath (NIMH), part of the National Institutes of Health, to Dartmouth’s Center for Technology and Behavioral Health (CTBH).
“This is an ambitious project with a lot of partners and a broad array of stakeholders, including researchers, governmental organizations, patient advocacy organizations, insurance company payers, and non-governmental and multilateral organizations in both the United States and Latin America,” says Lisa Marsch, PhD, director of CTBH and the project’s principal investigator.
U.S. Rep. Ann McLane Kuster and Dr. Nora Volkow join opioid crisis talks at Dartmouth
‘U.S. Rep. Kuster ’78 Joins Opioid Crisis Talks at Dartmouth’ (Dartmouth News– May 24, 2017 – Full Article)
U.S. Rep. Ann McLane Kuster ’78, founder and co-chair of the House Bipartisan Heroin Task Force, and Nora Volkow, director of the National Institute on Drug Abuse (NIDA), are coming to Dartmouth next week to hear about new treatment and prevention methods developed to confront the spike in opioid overdose deaths in New Hampshire.
Read MoreCTBH in the News! A global literature review of digital technology in the prevention and treatment of mental disorders in low- and middle- income countries
‘Evaluating the Feasibility and Accessibility of Digital Technology Interventions for Global Mental Health’ (Geisel NewsCenter – April 20, 2017 – Full Article)
Article Excerpt: “Lead author John A. Naslund, MPH, a doctoral candidate at The Dartmouth Institute for Health Policy and Clinical Practice, and an affiliate of Dartmouth’s Center for Technology and Behavioral Health, wrote the paper along with colleagues at Dartmouth, the London School of Hygiene and Tropical Medicine, the Public Health Foundation of India, and the University of Washington. Though he believes technology has the potential to positively affect the treatment of mental disorders, he admits it is not a panacea, but rather a valuable tool whose use should be based on evidence.”
This paper was published in Lancet Psychiatry
CTBH represented at Capitol Hill congressional briefing on the nation’s crisis with synthetic opioids and CTBH’s related work
The House Bipartisan Heroin Task Force held a roundtable to hear from physicians and public health advocates about heroin and synthetic drug abuse. Topics covered how these drugs affect the brain, communication between doctors and families on treatment plans for drug abusers, the need for alternative pain medicine, and the potency of synthetic drugs.
Watch video on C-SPAN
CTBH in the News! CTBH receives five-year $6.8 million renewal grant award from NIDA
Launched five years ago CTBH—a National Institute of Drug Abuse (NIDA)-funded Center of Excellence—conducts advanced research in the use of digital technology for understanding behavioral health, particularly substance use disorders (SUD) and mental health, and develops and validates new scientific-based interventions to help people overcome or manage their medical conditions.
Read MoreDartmouth receives award to scale-up science-based mental health care in Latin America
The U.S. National Institute of Mental Health has awarded a U19 Cooperative Agreement Grant to the Center for Technology and Behavioral Health at Dartmouth College. This award will support a partnership with a broad array of stakeholders, including leading researchers in the U.S. and Latin America, governmental organizations, patient advocacy organizations, insurance company payers, and non-governmental and multilateral organizations to scale-up mental health implementation research and build sustainable research capacity and science-based policies and programs in Latin America.
CTBH in the News! Geisel Receives $5 million NIH Grant to Study Motivation and Behavior Change to Improve Health
The Geisel School of Medicine’s Center for Technology and Behavioral Health (CTBH) has been awarded a $5 million Common Fund grant that spans two funding phases across five years from the National Institutes of Health (NIH). Common Fund grants support projects that cut across disciplines and populations.
Read MoreCTBH in the News! Dartmouth Receives NIH Grant to Launch Northeast Node of National Drug Abuse Clinical Trials Network
The National Institute on Drug Abuse (NIDA) has awarded a five-year $3.8 million grant to Geisel School of Medicine at Dartmouth’s Center for Technology and Behavioral Health. The award will support the launch of the new Northeast Node in NIDA’s National Clinical Trials Network (CTN), and clinical trials conducted by the Node will be supported by additional research project grants from NIDA, which is part of the National Institutes of Health.
Read MoreOverview of Technology-based Interventions (TBIs) for Substance Use Disorders
A video featuring Dr. Lisa Marsch, Director of the Center for Technology and Behavioral Health, is featured as part of the Addiction Technology Transfer Center Network’s “Telehealth Tuesday” series. In this downloadable video, Dr. Marsch discusses the benefits of utilizing telehealth technologies to deliver behavioral health services, including using the Therapeutic Education System (TES). Key benefits of using TES will be presented, including how it can provide patients/clients and clinicians the tools needed to facilitate integration of behavioral and physical healthcare in ways that transcend the boundaries of the clinic to offer a mechanism for achieving improved health and social well-being.
New book publication from Oxford University Press!
This edited book defines the state of scientific research related to the development, experimental evaluation, and effective dissemination of technology-based therapeutic tools targeting behavioral health.
Read More‘Road to Recovery September 2014: Using New Technologies To Expand Treatment and Recovery Services’
CTBH Director Lisa Marsch is featured in a video by the Substance Abuse and Mental Health Services Administration as part of a series aiming to inform and engage individuals and communities around substance abuse prevention and treatment and mental health issues.
Read MoreCTBH in the News! Mobile apps open up new possibilities for mental health care
Do people use these apps? Do they actually work? And how do you make sure the people who might benefit most from these tools actually engage with them?
Read MoreMaking Apps and Web-based Tools Part of Your Integrated Behavioral Health Team
Webinar participants heard about how one health center uses new behavioral HIT patient engagement tools in their integrated behavioral health care services.
Read MoreRegister today for a free webinar: ‘Making Apps and Web-based Tools Part of Your Integrated Behavioral Health Team’
Health Information Technology (HIT) makes it possible for individuals to access their health information online and also supports care coordination among health care providers. But how else can provider organizations use HIT to support the integration of behavioral health in primary care?
Read MoreCTBH in the News! CTBH featured in Geisel School of Medicine news release
‘There’s An App for That—Integrating devices and gadgets into clinical practice’ (February 3, 2014)
Article Excerpt: Health apps for smartphones are nothing new. There are a plethora of devices and gadgets available to help us manage our own health and wellness—fitness apps tracking diet and exercise are the most common. And health-care providers are increasingly using sophisticated technology-based medical applications to help patients manage chronic illnesses. Recently, there has also been an increase in applications designed to address behavioral health, including substance abuse and mental illness.
CTBH at the White House!
Several CTBH Investigators presented at the Technology Innovations for Substance Use and Mental Health Disorders Conference at the White House.
Read MoreCTBH Co-Hosts Conference on Application of Mobile Computing Technologies to Health and Wellness
CTBH collaborated with the Institute for Security, Technology, and Society at Dartmouth College and the Center for Digital Strategies at the Tuck School of Business at Dartmouth College in hosting a conference on the application of mobile health (mhealth) applications in an evolving healthcare context.
Read MoreAnnouncing new Development Center for Enhancing Evidence-Based Supported Employment with Technology
Sarah Lord, Ph.D., Director of Dissemination and Implementation at CTBH, and colleagues at the Dartmouth Psychiatric Research Center (PRC) were recently awarded a 5-year development center grant from the Department of Education, National Institute for Disability and Rehabilitation Research.
Read MoreJust published! Special Issue on Technology and Psychiatric and Substance Use Disorders
This Special Issue in Journal of Dual Diagnosis was Co-Edited by CTBH Director, Lisa A. Marsch, Ph.D. and CTBH Faculty Affiliate, Dror Ben-Zeev, Ph.D.
Read MoreCTBH in the News! Lisa A. Marsch, PhD is featured in the most recent edition of Dartmouth Medicine
Lisa A. Marsch, PhD – Director of the Center for Technology and Behavioral Health, is featured in the most recent edition of Dartmouth Medicine: The Magazine of The Geisel School of Medicine at Dartmouth.
Center Launches in New Space at Dartmouth College
Established in July of 2011, The Center for Technology and Behavioral Health (CTBH) is housed within the Dartmouth Psychiatric Research Center (PRC) in Lebanon, NH. Offices are located on the fourth floor of the Rivermill Commercial Center, a renovated mill building on the Mascoma River that dates back to 1881. To accommodate the CTBH team, the PRC acquired and renovated additional office and conference room space in the same building. To mark the completion of renovations, PRC and CTBH members celebrated with an Open House. While an essential component of the CTBH is virtual, with an interdisciplinary team of researchers located in institutions across the country, this newly expanded space provides the Dartmouth team members with an enhanced work environment and room to grow.
Center Opens 2011-2012 Seminar Series
The Center for Technology and Behavioral Health has opened a monthly seminar series. These presentations feature members of both the Scientific and Dissemination & Implementation Advisory Boards and other distinguished collaborators. The goal is to educate the CTBH team about a given Board member’s area of expertise and the most cutting-edge developments in their field of relevance to the Center’s Aims. Featured speakers to date include David Gustafson, Ph.D., who spoke about the growing evidence-based for Smartphone systems to improve patient outcomes. Linda Collins, Ph.D., from Penn State discussed the innovative Multiphase Optimization Strategy (MOST) for designing new behavioral interventions, and Robert Evans from Google presented PACO, his team’s open source mobile experience sampling research platform.
The seminar series is video recorded and available for viewing in the Seminar Series section of this website.